Clinical Trial Update: Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2, single-arm clinical trial evaluating Foscan-based photodynamic therapy for non-curatively resectable cholangiocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Foscan (temoporfin)

Snippet

Sponsor: University of Salzburg | Conditions: Non-curative Resectable Bile Duct Carcinoma | Phase 2 | Status: UNKNOWN